Advanced Biological Laboratories SA (ABL) Settles Its Dispute with Stanford University and Endorses Stanford's HIVdb Website and Other Globally Available Research and Not-for-Profit Websites
6/22/2009 8:30:46 AM
LUXEMBOURG--(BUSINESS WIRE)--Advanced Biological Laboratories SA (ABL) announced today that it has signed a Patent Immunity Agreement and has dismissed all claims against Stanford University, thus resolving any disputes related to ABL US patents 6.081.786, 6.188.988 and their foreign equivalents, ensuring the free access for all uses to Stanford and all the Stanford researchers and related parties. In exchange, ABL obtained free access to Stanford’s US Patents RE38352, 5.856.086 and 5.631.128 and their foreign equivalents.
comments powered by